Aavrani Dry Scalp Rescue Serum

Description

The product is identified by the SPL code 34089-3. No specific description details are provided in the text.

Uses and Indications

This drug is indicated for the relief of scalp flaking, itching, and irritation associated with dandruff.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The medication should be applied to the affected areas one to four times daily, or as directed by a healthcare professional.

To administer, part the hair and apply the product directly to the scalp using the nozzle tip, ensuring to focus on the problem areas. After application, gently massage the product into the scalp. The hair can then be styled as usual; it is important to note that the product should not be rinsed out after application.

Contraindications

Use is contraindicated in individuals with a known allergy to any of the ingredients listed.

Warnings and Precautions

For external use only. Prior to using this product, it is essential for healthcare professionals to assess the patient's condition, particularly in pregnant or breastfeeding individuals. The product should not be administered to patients with known allergies to any of the ingredients listed.

Healthcare professionals should advise patients to avoid contact with the eyes during application. In the event of accidental eye contact, it is crucial to rinse the eyes thoroughly with water to mitigate potential irritation.

Patients should be instructed to discontinue use and consult a healthcare provider if their condition worsens or fails to improve after consistent application of the product as directed.

Additionally, it is imperative to keep this product out of reach of children. In cases of ingestion, immediate medical assistance should be sought, or contact with a poison control center should be made without delay.

Side Effects

Patients should be aware that this product is for external use only. It is contraindicated in individuals who are allergic to any of the ingredients listed. During use, it is important to avoid contact with the eyes; in the event of contact, patients should rinse their eyes thoroughly with water.

Patients are advised to discontinue use and consult a healthcare professional if their condition worsens or does not improve after regular use of the product as directed. Additionally, this product should be kept out of reach of children. In the case of accidental ingestion, immediate medical assistance should be sought or a poison control center contacted.

Drug Interactions

There are no documented drug interactions associated with the use of this medication. Additionally, there are no reported interactions between this drug and laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Aavrani Dry Scalp Rescue Serum (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a poison control center is recommended.

Geriatric Use

There is no specific information regarding the use of AAVRANI DRY SCALP RESCUE SERUM in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when administering this product to elderly patients, as the absence of data necessitates careful monitoring and consideration of individual patient factors.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional, such as a doctor or pharmacist, prior to using this medication. It is essential to evaluate the potential risks and benefits associated with the use of this drug during pregnancy and lactation. The safety of this medication in pregnant women has not been established, and caution is advised to ensure the well-being of both the mother and the fetus.

Lactation

Lactating mothers should consult with a healthcare professional, such as a doctor or pharmacist, prior to using this medication if they are pregnant or breastfeeding. There is no specific data available regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, careful consideration and professional guidance are recommended to ensure the safety of both the mother and the nursing infant.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the absence of specific guidance may necessitate individualized assessment and monitoring based on clinical judgment.

Hepatic Impairment

There is no information available regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise caution and consider the lack of data when prescribing this medication to patients with liver problems.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical assistance or contact a poison control center without delay.

Prompt action is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved, and healthcare providers should be prepared to assess and manage these symptoms accordingly.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous monitoring and evaluation are recommended to ensure patient safety and effective resolution of any complications arising from the overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a poison control center if the product is swallowed. It is essential to inform patients not to use the product if they have a known allergy to any of its ingredients.

Patients should be instructed to discontinue use and consult a doctor if their condition worsens or does not improve after following the recommended usage directions. Additionally, healthcare providers should emphasize the importance of avoiding contact with the eyes while using the product. In the event of accidental eye contact, patients should be directed to rinse their eyes thoroughly with water.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain its integrity. It should be stored at room temperature, away from direct light exposure to protect its quality. Once opened, the product should be discarded to ensure safety and efficacy.

Additional Clinical Information

Patients should apply the medication to affected areas one to four times daily, or as directed by a clinician. The application involves parting the hair and applying the product directly to the scalp using the nozzle tip, with a focus on problem areas. After application, patients are advised to gently massage the product into the scalp and style their hair as usual, without rinsing.

No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Aavrani Dry Scalp Rescue Serum, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)